BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6185195)

  • 1. VAB-6 combination chemotherapy in resected stage II-B testis cancer.
    Vugrin D; Whitmore WF; Herr HW; Sogani P; Golbey RB
    Cancer; 1983 Jan; 51(1):5-8. PubMed ID: 6185195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer.
    Vugrin D; Whitmore WF; Herr H; Sogani P; Golbey RB
    J Urol; 1982 Oct; 128(4):715-7. PubMed ID: 6183456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis.
    Vugrin D; Whitmore WF; Golbey RB
    Cancer; 1983 Jan; 51(2):211-5. PubMed ID: 6185197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors.
    Vugrin D; Whitmore WF; Golbey RB
    Cancer; 1983 Mar; 51(6):1072-5. PubMed ID: 6185211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VAB-6 combination chemotherapy in disseminated cancer of the testis.
    Vugrin D; Herr HW; Whitmore WF; Sogani PC; Golbey RB
    Ann Intern Med; 1981 Jul; 95(1):59-61. PubMed ID: 6166230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VAB-6 regimen in the treatment of metastatic seminoma.
    Vugrin D; Whitmore WF
    Cancer; 1984 Jun; 53(11):2422-4. PubMed ID: 6201259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
    Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
    J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
    Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
    Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

  • 12. VAB-3 combination chemotherapy in primary mediastinal germ cell tumors.
    Vugrin D; Martini N; Whitmore WF; Golbey RB
    Cancer Treat Rep; 1982 Jun; 66(6):1405-7. PubMed ID: 6177411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
    Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
    J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancer.
    Vugrin D; Whitmore W; Cvitkovic E; Grabstald H; Sogani P; Golbey RB
    Cancer; 1981 Jul; 48(2):233-7. PubMed ID: 6165458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infusion of high doses of platidiam in the treatment of patients with germ cell testicular tumors].
    Tiuliandin SA
    Vopr Onkol; 1990; 36(1):89-92. PubMed ID: 1689528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphadenectomy for testicular carcinoma.
    Laplante MP; Mount BM
    Can J Surg; 1982 May; 25(3):262-6. PubMed ID: 6177391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
    Fizazi K; Do KA; Wang X; Finn L; Logothetis CJ; Amato RJ
    Ann Oncol; 2002 Jan; 13(1):125-34. PubMed ID: 11863094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study].
    Göbel U; Bamberg M; Haas RJ; Bökkerink JP; Brämswig G; Calaminus G; Engert J; Gadner H; Havers W; Janka-Schaub GE
    Klin Padiatr; 1989; 201(4):247-60. PubMed ID: 2476583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
    Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of chemotherapy in patients with disseminated testicular tumors].
    Abdyldaev TA; Tiuliandin SA; Batov SV
    Vopr Onkol; 1990; 36(1):85-9. PubMed ID: 1689527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.